ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™ (NCT06608823)
A Study to Assess Safety and Effectiveness of the JenaValve Trilogy™ Transcatheter Heart Valve System Versus Surgical Valve Replacement in Patients With Aortic Regurgitation
🩺 Plain-English Summary (8th-Grade Level)
To demonstrate non-inferiority of the Trilogy Transcatheter Heart Valve (THV) System compared with surgical aortic valve replacement (SAVR) for treatment of subjects with clinically significant native aortic regurgitation (AR)
Who can join: Review the eligibility criteria below.
Location: CPMC Sutter Health — Burlingame, California
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (29 Sites)
Showing the first 25 of 29 sites.
- CPMC Sutter Health — Burlingame, California
- Scripps Health — La Jolla, California
- Cedars-Sinai Medical Center — Los Angeles, California
- Los Robles Medical Center — Thousand Oaks, California
- MedStar Washington Hospital Center — Washington D.C., District of Columbia
- BayCare Health — Clearwater, Florida
- HCA North Florida — Gainesville, Florida
- Emory University Hospital — Atlanta, Georgia
- Piedmont Healthcare — Atlanta, Georgia
- Heart Care Centers of IL / Hinsdale Hospital — Chicago, Illinois
- Ascension St. Vincent Heart Center — Carmel, Indiana
- Beth Israel Deaconess Medical Center — Boston, Massachusetts
- University of Michigan — Ann Arbor, Michigan
- Henry Ford Health — Detroit, Michigan
- Minneapolis Heart Institute Foundation — Minneapolis, Minnesota
- Washington University - Barnes Jewish Hospital — St Louis, Missouri
- Robert Wood Johnson University Hospital — New Brunswick, New Jersey
- Buffalo General Medical Center — Buffalo, New York
- Columbia University Medical Center — New York, New York
- The Christ Hospital — Cincinnati, Ohio
- The Cleveland Clinic Foundation — Cleveland, Ohio
- Ohio Health — Columbus, Ohio
- Oregon Health & Science University (OHSU) — Portland, Oregon
- Lankenau Institute for Medical Research — Philadelphia, Pennsylvania
- Houston Methodist Research Institute — Houston, Texas
📞 Contact the Study Coordinator
Phone: (949) 767-2110
Email: pinto@jenavalve.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Aortic Regurgitation
- The JenaValve ALIGN-AR Pivotal Trial — Tucson, Arizona
- The JenaValve ALIGN-AR LVAD Registry — Los Angeles, California
- THE ALIGN-AR EFS TRIAL: JenaValve Pericardial TAVR Aortic Regurgitation Study — Los Angeles, California
- Novel Characterization of Sex Specific Biologic Signatures in Valvular Heart Disease — Cleveland, Ohio
Explore by condition: All Aortic Regurgitation clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.